Overview
Valued at
~$1.32 billion in 2023, the mechanical heart valve market is projected to reach
~$1.58 billion by 2028, increasing at a
CAGR of 3.7% over the 2023-2028
forecast period. This Market Snapshot is part of
LSI’s Market Intelligence platform, your
one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and
deal-tracking, curated insights, and more.
Mechanical heart valves are used to replace or repair the natural tissue valve of the heart damaged due to
disease or old age. These valves are generally made of non-biological materials with a mobile occluder made from
rigid materials. Mechanical heart valves are implanted through an open-heart surgical procedure, offering a
durable solution for younger, low-risk patients.
Mechanical heart valves are part of the larger heart valve repair and replacement devices market, which also
contains
tissue
heart valves and transcatheter
aortic,
mitral,
tricuspid,
and
pulmonary
valves.
Products included within the scope of this analysis include:
This Market Snapshot is intended to provide a high-level overview of the global market for mechanical heart
valves, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups
Mechanical Heart Valve Market Snapshot Summary
| Snapshot Aspect |
Data and Details |
| Base Year for Estimate |
2023 |
| Forecast Period |
2023 - 2028 |
| Market Size in 2023 |
$1.32 billion |
| CAGR |
3.7% |
| Projected Market Size in 2028 |
$1.58 billion |
Mechanical Heart Valve Market Insights
Total heart valve repair and replacement unit volume is projected to grow at a steady rate from 2023 to 2028,
reflecting the projected rate of increase in hospital admissions for heart valve disease worldwide combined with
the impact of less invasive transcatheter technologies. While the transcatheter segment is expected to see
robust growth, mechanical valve replacement procedures will gradually decline, with market growth largely
sustained by inflation. The total sales of mechanical heart valves are projected to increase at a CAGR of 3.7%,
as the rising cost of these valves contributes to an overall increase in market value.
Despite the shift towards minimally invasive solutions, mechanical heart valves remain relevant due to their
long-term durability, which is crucial for certain patient populations. Companies like Medtronic and Artivion
recently reported a temporary uptick in demand for surgical valves as clinical evidence continues to support
their use for patients who require longevity and survival benefits.
Competitive Landscape
The full Market Snapshot includes a robust analysis of the competitive landscape for the mechanical heart valve
market. This includes estimated market revenue and market share for key players, such as Abbott and Medtronic.
Select Market Events
|
Company
|
Date
|
Type
|
Event
|
|
|
1/2024
|
Fundraising
|
Artivion announced the company had secured $350 million in a non-dilutive credit agreement
to help the company optimize for growth.
|
Key Companies Covered
Abbott
Artivion
Medtronic
